Quality of life (QoL) has become an important outcome indicator in health care evaluation. A
clear distinction has to be made between QoL–focussing on individuals' subjective …

Buprenorphine maintenance therapy (BMT) is increasingly the preferred opioid
maintenance agent due to its reduced toxicity and availability in an office-based setting in …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Background To examine the association of current and past Opiate Use Disorder (OUD) with
measures of HRQOL and employment in a nationally representative sample of adults …

Purpose This study explores the current QoL of opiate-dependent individuals who started
outpatient methadone treatment at least 5 years ago and assesses the influence of …

Background: There is a knowledge gap in systematic reviews on the impact of opioid agonist
treatments on mental health. Objectives: We compared mental health outcomes between …

Background Opioid substitution treatments are effective in retaining people in treatment and
suppressing heroin use. An open question remains whether slow‐release oral morphine …

Purpose This longitudinal study assessed the changes in drug use patterns and health-
related quality of life (HRQL) among HIV-positive drug users in the first methadone …

Objective To assess the efficacy of slow release oral morphine (SROM) as a treatment for
opioid use disorder (OUD). Design Systematic review and meta-analysis of randomised …

Background Opioid dependence is associated with high levels of morbidity, yet sparse data
exists regarding the health-related quality of life (HRQoL) of individuals with opioid …